Announcements Trials
Browse Landscape

Status

Recruiting 5797Active not recruiting 2952Completed 1685Not yet recruiting 1596Terminated 371Enrolling by invitation 177Suspended 128Withdrawn 102Available 27No longer available 4Approved for marketing 2Temporarily not available 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Expanded_access 4

Sponsor

Cancer Type

Thoracic 2Sarcoma 1Plasma cell 1Lymphoid 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Osteosarcoma 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1Granuloma, Plasma Cell 1Glioblastoma 1Adenocarcinoma of Lung 1

Interventions

gallium maltolate 1ceritinib 1capmatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
No longer available × 90 days × Clear all
NCT07560709 2026-05-01

Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent Osteosarcoma

University of Florida

No longer available
Sarcoma

Osteosarcoma

NCT05100134 2026-04-01

Managed Access Programs for LDK378, Ceritinib

Novartis

No longer available
LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT04741789 2026-03-16

Managed Access Programs for INC280, Capmatinib

Novartis

No longer available
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06404034 2026-03-04

Expanded Access to Gallium Maltolate (GaM)

Imaging Biometrics, LLC

No longer available
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡